Table 5 HbA1c pattern, N = 105
From: Dipeptidyl Peptidase-4 inhibitors use in type II diabetic patients in a tertiary hospital
HbA1c | Pre DPP-4i use n (%) | Post DPP-4i use n (%) |
|---|---|---|
< 6.5% | 8 (7.6) | 21 (20.0) |
6.5–9.9% | 76 (72.4) | 70 (66.7) |
≥10% | 21 (20.0) | 14 (13.3) |